Test results, essential for quality healthcare, constitute more than 70% of patients’ health records. Because quality results are so important, governments around the world mandate a series of laboratory practices to ensure quality.  All laboratories in the United States follow the Clinical Laboratory Improvement...

Sepsis is a major cause of mortality and morbidity for hospitalized patients around the world. Early intervention can reduce mortality and morbidity from severe sepsis, but signs and symptoms of sepsis are non-specific. Point-of-care lactate has proved to be an invaluable tool for some institutions in standardized...

The field of point-of-care testing (POCT) is entering a period of rapid expansion. This expansion is being driven by new evidence for clinical effectiveness of POCT, and new technologies that allow consolidation of testing onto smaller platforms. Technological improvements will also lead to increased accuracy for...

Although creatinine clearance has been the mainstay for estimating glomerular filtration rate (GFR) in laboratories for the past half-century, prediction equations based on serum creatinine and other routine serum analytes are now available which enable reporting of a calculated GFR using the Modification of Diet in...

In the U.S. all clinical laboratory determinations, including blood gas testing performed at point of care (POC) or in the central laboratory, is regulated by the Clinical Laboratory Improvement Amendments of 1988 (CLIA).  Congress passed CLIA to ensure accurate, reliable, and timely test results regardless of...

In a 1999 study, the US Institute of Medicine (IOM) concluded that 44,000 to 98,000 hospitalized Americans die each year from preventable medical errors. While the number of serious medical errors attributable to point of care (point-of-care testing, POCT) is not known, the testing environment (patient bedside) and...

In the U.S. all testing, including decentralized testing, is regulated according to the Clinical Laboratory Improvement Amendments of 1988 (CLIA'88). Congress passed CLIA'88 to ensure accurate, reliable, and timely test results regardless of test site. These quality control, quality assurance, and proficiency tesing...

There are several diagnostic approaches to identify and quantify different types of vascular disease. However, these methods usually do not reflect the condition of the cutaneous circulation.  Because transcutaneous oxygen reveals the status of cutaneous circulation, it has been shown to be a powerful diagnostic tool ...